The Pregnane X Receptor Locus Is Associated With Susceptibility to Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

The Pregnane X Receptor Locus Is Associated With Susceptibility to Inflammatory Bowel Disease

Published:2006-02 Issue:2 Volume:130 Page:341-348
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Dring Megan M.,Goulding Carol A.,Trimble Valerie I.,Keegan Denise,Ryan Anthony W.,Brophy Karen M.,Smyth Claire M.,Keeling P.W. Napoleon,O’Donoghue Diarmuid,O’Sullivan Maria,O’Morain Colm,Mahmud Nasir,Wikström Ann–Charlotte,Kelleher Dermot,McManus Ross

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking;Tysk;Gut,1988

2. Familial occurrence of inflammatory bowel disease;Orholm;N Engl J Med,1991

3. Inflammatory bowel disease;Hugot;Best Pract Res Clin Gastroenterol,2004

4. Inflammatory bowel disease in a Swedish twin cohort;Halfvarson;Gastroenterology,2003

5. Clinical relevance of advances in genetics and pharmacogenetics of IBD;Ahmad;Gastroenterology,2004

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of PXR in drug metabolism: chemical and structural perspectives;Expert Opinion on Drug Metabolism & Toxicology;2024-01-28

2. Microbial metabolites are involved in tumorigenesis and development by regulating immune responses;Frontiers in Immunology;2023-12-19

3. Artemisinins: Promising drug candidates for the treatment of autoimmune diseases;Medicinal Research Reviews;2023-12-06

4. Aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR) play both distinct and common roles in the regulation of colon homeostasis and intestinal carcinogenesis;Biochemical Pharmacology;2023-10

5. Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic–pharmacokinetic and exposure–response analysis;Cancer Chemotherapy and Pharmacology;2023-07-27